(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.86%.
Anixa Biosciences's earnings in 2026 is -$10,382,000.On average, 6 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,701,496, with the lowest ANIX earnings forecast at -$12,264,669, and the highest ANIX earnings forecast at -$11,315,618. On average, 6 Wall Street analysts forecast ANIX's earnings for 2027 to be -$11,878,791, with the lowest ANIX earnings forecast at -$12,605,355, and the highest ANIX earnings forecast at -$11,315,618.
In 2028, ANIX is forecast to generate -$12,647,071 in earnings, with the lowest earnings forecast at -$13,627,410 and the highest earnings forecast at -$11,315,618.